佛罗里达州注射吸毒的医院费用。
Hospital Costs of Injection Drug Use in Florida.
机构信息
University of Miami Miller School of Medicine, Miami, Florida, USA.
Department of Public Health Sciences, Division of Biostatistics, Biostatistics Collaboration and Consulting Core, University of Miami Miller School of Medicine, Miami, Florida, USA.
出版信息
Clin Infect Dis. 2021 Feb 1;72(3):499-502. doi: 10.1093/cid/ciaa823.
Abstract
People who inject drugs (PWID) experience significant injection-related infections (IRIs) at significant healthcare system cost. This study used and validated an algorithm based on the International Classification of Diseases, Tenth Revision, to estimate hospitalized PWID populations, assess the total statewide morbidity for IRIs among PWID, and calculate associated costs of care.
摘要
注射毒品者（PWID）在医疗保健系统中会经历大量与注射相关的感染（IRIs），并产生高昂的成本。本研究使用并验证了一种基于国际疾病分类第十版的算法，以估计住院 PWID 人群，评估 PWID 中与注射相关感染的全州发病率，并计算相关的医疗费用。
相似文献
1
Hospital Costs of Injection Drug Use in Florida.佛罗里达州注射吸毒的医院费用。
Clin Infect Dis. 2021 Feb 1;72(3):499-502. doi: 10.1093/cid/ciaa823.
2
A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida.佛罗里达州迈阿密一家县安全网医院与注射吸毒相关感染住院治疗的成本分析。
PLoS One. 2015 Jun 15;10(6):e0129360. doi: 10.1371/journal.pone.0129360. eCollection 2015.
3
A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida.错失的机会：佛罗里达州未能充分利用住院行为健康服务减少注射毒品使用后遗症。
Subst Abuse Treat Prev Policy. 2021 May 31;16(1):46. doi: 10.1186/s13011-021-00383-w.
4
Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.英国注射吸毒者的颈静脉注射情况：患病率、相关因素及危害
Int J Drug Policy. 2017 Aug;46:28-33. doi: 10.1016/j.drugpo.2017.05.005. Epub 2017 Jun 3.
5
Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.与住院吸毒者皮肤和软组织感染相关的危险因素。
J Addict Med. 2017 Nov/Dec;11(6):461-467. doi: 10.1097/ADM.0000000000000346.
6
'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.“Care and Prevent”：在伦敦调查注射吸毒人群中的皮肤和软组织感染及 AA 淀粉样变性的基本原理。
Harm Reduct J. 2018 May 8;15(1):23. doi: 10.1186/s12954-018-0233-y.
7
Infectious Complications in Injection Drug Use.注射毒品使用中的感染性并发症。
MedEdPORTAL. 2021 Mar 23;17:11124. doi: 10.15766/mep_2374-8265.11124.
8
Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017.评估 2016-2017 年佛罗里达州阿片类药物和兴奋剂使用相关传染病住院治疗的差异。
Clin Infect Dis. 2021 Oct 5;73(7):e1649-e1657. doi: 10.1093/cid/ciaa1278.
9
Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.注射吸毒人群感染性心内膜炎的长期手术结局：系统评价和荟萃分析。
BMC Infect Dis. 2019 Nov 8;19(1):918. doi: 10.1186/s12879-019-4558-2.
10
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.调查使用注射器服务项目的注射吸毒者的风险行为和注射器覆盖率：潜在类别分析
Int J Drug Policy. 2020 Apr;78:102716. doi: 10.1016/j.drugpo.2020.102716. Epub 2020 Mar 5.
引用本文的文献
1
Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients', community organization and healthcare workers' perspectives.探索针对注射毒品且因细菌感染住院患者的患者导航计划的价值和可接受性：患者、社区组织及医护人员的观点。
BMC Infect Dis. 2025 Feb 14;25(1):221. doi: 10.1186/s12879-025-10617-y.
2
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.考察对接受阿片类物质使用障碍治疗的注射阿片类药物参与者给予更高维持剂量的丁丙诺啡缓释制剂的益处。
Harm Reduct J. 2023 Dec 2;20(1):173. doi: 10.1186/s12954-023-00906-7.
3
Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs.减少伤害：注射吸毒患者整体护理中缺失的一环。
Open Forum Infect Dis. 2023 Jul 25;10(8):ofad402. doi: 10.1093/ofid/ofad402. eCollection 2023 Aug.
4
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.注射吸毒相关感染的传染病和物质使用障碍综合团队的实施：一项定性研究。
Addict Sci Clin Pract. 2023 Feb 7;18(1):8. doi: 10.1186/s13722-023-00363-4.
5
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey.南佛罗里达州门诊和住院药房阿片类药物使用障碍药物的供应情况：秘密购物者调查。
Addict Sci Clin Pract. 2022 Nov 18;17(1):63. doi: 10.1186/s13722-022-00346-x.
6
Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.机器学习算法在局部注射器服务项目政策实施中的应用 - 佛罗里达州，2017 年。
Ann Med. 2022 Dec;54(1):2137-2150. doi: 10.1080/07853890.2022.2105391.
7
Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study.住院的阿片类药物相关诊断患者中的急性疼痛和自我导向出院：一项队列研究。
Harm Reduct J. 2021 Dec 16;18(1):131. doi: 10.1186/s12954-021-00581-6.
8
Implementation and first-year operating costs of an academic medical center-based syringe services program.学术医疗中心为基础的针具服务项目的实施和第一年运营成本。
Harm Reduct J. 2021 Nov 19;18(1):116. doi: 10.1186/s12954-021-00563-8.
9
Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.减少危害以治疗严重注射相关感染的患者：杰克逊 SIRI 团队的描述。
Ann Med. 2021 Dec;53(1):1960-1968. doi: 10.1080/07853890.2021.1993326.
10
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.在实施注射器服务计划后，佛罗里达州迈阿密的注射风险行为减少。
J Subst Abuse Treat. 2021 Aug;127:108344. doi: 10.1016/j.jsat.2021.108344. Epub 2021 Mar 3.
本文引用的文献
1
HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.在阿片类药物流行期间，对美国联邦合格健康中心的全国样本进行 HCV 检测和治疗。
J Gen Intern Med. 2020 May;35(5):1477-1483. doi: 10.1007/s11606-020-05701-9. Epub 2020 Mar 4.
2
Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017.美国 2010-2017 年商业保险人群中注射吸毒者的人类免疫缺陷病毒和丙型肝炎病毒感染检测。
J Infect Dis. 2020 Aug 17;222(6):940-947. doi: 10.1093/infdis/jiaa017.
3
Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers.在一项大型美国联邦合格健康中心样本中，对 13 至 21 岁人群进行丙型肝炎病毒抗体检测。
JAMA. 2019 Dec 10;322(22):2245-2248. doi: 10.1001/jama.2019.16196.
4
Changes in Infective Endocarditis Admissions in Pennsylvania During the Opioid Epidemic.宾夕法尼亚州阿片类药物流行期间感染性心内膜炎入院人数的变化。
Clin Infect Dis. 2020 Oct 23;71(7):1664-1670. doi: 10.1093/cid/ciz1038.
5
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.美国华盛顿州西雅图市监管注射设施的预计成本和收益。
Int J Drug Policy. 2019 May;67:9-18. doi: 10.1016/j.drugpo.2018.12.015. Epub 2019 Feb 23.
6
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.利用医疗保健管理数据集识别注射吸毒行为并估计注射吸毒人群规模。
Int J Drug Policy. 2018 May;55:31-39. doi: 10.1016/j.drugpo.2018.02.001. Epub 2018 Feb 23.
7
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况：多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
8
Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence - North Carolina, 2010-2015.2010 - 2015年北卡罗来纳州药物依赖确诊患者的心内膜炎住院情况及相关医疗费用
MMWR Morb Mortal Wkly Rep. 2017 Jun 9;66(22):569-573. doi: 10.15585/mmwr.mm6622a1.
9
Discharges Against Medical Advice at a County Hospital: Provider Perceptions and Practice.县医院违反医嘱出院情况：医护人员的认知与做法
J Hosp Med. 2017 Jan;12(1):11-17. doi: 10.1002/jhm.2672.
10
Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.注射毒品的年轻人中感染性心内膜炎入院病例不断增加。
Open Forum Infect Dis. 2016 Jul 26;3(3):ofw157. doi: 10.1093/ofid/ofw157. eCollection 2016 Sep.
Zotero 插件